Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Spinal Cord Neuroplasticity
Article type: Research Article
Authors: Henderson, Christopher E. | Bloch-Gallego, Evelyne | Camu, William | Gouin, Annie | Mettling, Clément
Affiliations: Centre de Recherche de Biochimie Macromoléculaire, UPR 9008 du CNRS/U249 de l'INSERM, B.P. 5051, 34033 Monlpellier CEDEX, (France)
Note: [] Correspondence: C.E. Henderson, Centre de Recherche de Biochimie Macromoléculaire, UPR 8402 du CNRS/U249 de I'INSERM, B.P. 5051, 34033 Montpellier CEDEX, (France)
Abstract: Factors affecting neuronal growth may be considered to fall into two major categories: those required for neuronal survival during development or following a lesion, and those which enhance growth or regeneration of axonal or dendritic processes. We briefly review here some recent studies on the former in spinal cord development and plasticity as an introduction to other papers in the session on Factors controlling Neural Growth, and then present in more detail work on factors affecting motoneuron development in vitro. The neurotrophins are a closely-related family of basic neurotrophic factors including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) and neurotrophins -3, -4 and -5 that enhance neuronal survival by binding to surface receptors whose major components are the trk tyrosine kinases and p75NGF-R. Only the latter has been studied in the context of spinal cord neuroplasticity: its levels on motoneurons are up-regulated following central or peripheral trauma, although its function there remains unknown. Much evidence exists for the existence of ‘motoneuron growth factors’ involved in regulation of survival and development of spinal motoneurons. Following a critical comparison of techniques for their purification, we review results obtained in vitro and in vivo using known growth factors such as ciliary neurotrophic factor (CNTF), basic fibroblast growth factor (bFGF) and transforming growth factor (TGF/β1). Although none of them satisfies all the criteria for the embryonic ‘motoneuron growth factor’, CNTF is of potential interest for reducing motoneuron loss in pathological situations.
Keywords: Motoneuron, Neuronal growth factor, Neurotrophin, Denervation, SCI antibody
DOI: 10.3233/RNN-1993-5105
Journal: Restorative Neurology and Neuroscience, vol. 5, no. 1, pp. 15-28, 1993
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl